Precision Delivery. Proprietary Platforms. Proven Absorption.
Avant Labs develops and licenses formulation and device platforms that stabilize and provide effective, targeted absorption of next-generation bio-actives.
Looking for our consumer wellness products? Visit our storefront.
Shop Now →Platform Architecture
Two Platforms. One Mission.
Avant Labs operates two independent, IP-protected delivery technology platforms — each engineered for a distinct absorption pathway, each capable of standalone licensing or co-formulation.
Buccal Thin-Film Delivery
Buccal Thin-Film Platform
A buccal thin-film matrices that bypass first-pass metabolism for rapid, high-bioavailability absorption of bio-actives. Engineered for precision dosing, stability under ambient conditions, and patient-compliant administration.
Topical Skin-Binding & Barrier Delivery
Topical Skin-Binding Platform
Proprietary topical carrier systems that bind active compounds to the dermal barrier for sustained, localized delivery without systemic exposure. Formulated for stability, skin compatibility, and measurable dermal retention.
For Investors
Seed Round Now Open
Avant Labs is raising a seed round. Review our technology thesis, IP portfolio, and market opportunity. Institutional and strategic investors welcome.
For Creators & Brands
Build With Our Platforms
Partner with a delivery technology platform built for the next wave of bio-active products. White-label, co-formulation, and creator programs available.